"Non-small Cell Lung Cancer Associated With Poorer Prognosis in Older Patients With IPF" - Eamon Dreisbach
Non-small cell lung cancer is associated with poorer prognosis and has a unique presentation in elderly patients with idiopathic pulmonary fibrosis, according to researchers at the Icahn School of Medicine at Mount Sinai. “One of the most interesting observations was that the rate of treatment for advanced cancer was lower in patients with lung fibrosis and lung cancer compared with those with lung cancer without lung fibrosis,” said author Charles Powell, MD, system chief of the division of pulmonary, critical care and sleep medicine at the Mount Sinai Health System and chief executive officer of the Mount Sinai-National Jewish Health Respiratory Institute. He added, “However, we do know that even though patients with advanced stage lung cancer have relatively low survival rates, treatment does improve length and quality of life.”
— Charles Powell, MD, System Chief, Division of Pulmonary, Critical Care and Sleep Medicine, Mount Sinai Health System, Chief Executive Officer, Mount Sinai – National Jewish Health Respiratory Institute
Mount Sinai Launches Institute for Airway Sciences
Jan 12, 2022 View All Press Releases